The DNA Synthesizer Market is estimated to be valued at US$ 4.30 Bn in 2023 and is expected to exhibit a CAGR of 20.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
The DNA Synthesizer market comprises products that synthesize DNA molecules by assembling nucleotides in an automated fashion as specified by the user. DNA synthesizers carry out chemical reactions to sequentially link nucleotides thus producing custom-made DNA strands for applications in molecular biology research and DNA sequencing. DNA synthesizers allow rapid, cost-effective production of oligonucleotides without extensive purification steps involved in traditional DNA synthesis methods.
Market key trends:
Rising focus on gene synthesis for various applications is a major factor fueling demand for DNA synthesizers. Gene synthesis enables researchers to build customized genes for various applications including vaccine and drug development. It facilitates rapid elucidation of gene functions for advancing genomics research. Gene synthesis is playing a key role in biosynthesis by enabling engineering of microbes for production of chemicals, materials and fuels. it allows rapid generation of genetically modified organisms (GMOs) and helps accelerate research on precision gene editing techniques like CRISPR. Leading players are focusing on developing high-throughput DNA synthesizers that can produce large libraries of customized DNA at reduced costs, thereby increasing scope and pace of gene synthesis applications. This will continue driving uptake of DNA synthesizers over the forecast period.
Porter's Analysis
Threat of new entrants: The DNA Synthesizer market faces moderate threat from new entrants as large capital investments are required for R&D, manufacturing, and strong distribution networks. However, the availability of new technologies provides opportunities.
Bargaining power of buyers: Buyers have moderate bargaining power due to the availability of substitute products and a wide range of product offerings from manufacturers.
Bargaining power of suppliers: Synthesizer manufacturers source raw materials from few suppliers, thereby increasing suppliers' bargaining power.
Threat of new substitutes: Moderate threat from substitutes exists as new technologies like DNA sequencing are emerging.
Competitive rivalry: Intense as major players compete on technological innovations, cost reductions, and global expansion.
SWOT Analysis
Strengths: Advanced technologies, large R&D investments, global presence.
Weaknesses: High capital requirements, stringent regulations, reliance on skilled workforce.
Opportunities: Increasing research activities, growing biotechnology & pharmaceutical industries, rising genomics applications.
Threats: Trade barriers, economic slowdowns, intellectual property risks.
Key Takeaways
The global DNA Synthesizer Market Growth is expected to witness high growth at a CAGR of 20% over the forecast period, due to increasing demand for synthesized genes from biotechnology and pharmaceutical companies for drug discovery and therapeutic development.
Regionally, North America dominates the global market and is expected to maintain its lead over 2023-2030 due to higher research expenditures and a strong foothold of leading synthetic DNA manufacturers in the US. Europe and Asia Pacific are fastest growing regions attributed to rising R&D investments, growing genomics industry and increasing healthcare expenditures.
Key players operating in the DNA Synthesizer market are Thermo Fisher Scientific, Merck KGaA, Agilent Technologies, Danaher Corporation (Integrated DNA Technologies), GenScript Biotech Corporation, Eurofins Genomics, LGC Limited, BioAutomation Corporation, Bio-Rad Laboratories, Twist Bioscience Corporation, Hamilton Company, Expedeon AG, New England Biolabs, Nippon Genetics, LGC Biosearch Technologies. Major players are focused on product advancements through M&A and partnership activities to strengthen their geographic presence.
Read More,
https://www.newsstatix.com/dna-synthesizer-market-trends-size-and-share-analysis/
DecisionDatabases recently present the global DNA Vaccines Market research report 2020 which reveals an extensive analysis of the global industry by delivering detailed information about upcoming market growth, trends, customer expectations, technological improvements, competitive dynamics, top manufacturers' assessment, and working capital in the industry.
This is an in-depth study of the market enlightening key forecast to 2025.The global DNA vaccines market report presents a complete research-based study of the industry including details such as company shares, forecast data, in-depth analysis and an outlook of the market on a worldwide platform.
The report further highlights the market drivers, restraints and the top manufacturers at the global and regional levels.
For a thorough understanding, the report also offers market segmentation and regional analysis for the forecast period from 2020 to 2025.According to this study, over the next five years, the DNA Vaccines market will register an 8.3% CAGR in terms of revenue, the global market size will reach US$ 5490 million by 2025, from US$ 3690 million in 2019.
The advent of these vaccines has revolutionized the healthcare market.
Following North America, Europe is the second-largest consumption place with a revenue market share of 28% in 2018.
